Home / Article

Psychedelic Passage and Miraculix Collaborate to Enhance Safety in Psychedelic Therapy

Maverick PR, Your Source for Cannabis and Psychedelics News April 23, 2024
By CharityAce News Staff
Read Original Article →
Psychedelic Passage and Miraculix Collaborate to Enhance Safety in Psychedelic Therapy

Summary

The partnership between Psychedelic Passage and Miraculix aims to improve the safety and effectiveness of psychedelic therapy through scientific analysis and community research.

Full Article

The collaboration between Psychedelic Passage, a service connecting clients with pre-vetted psychedelic facilitators, and Miraculix, a leader in the analysis of psychoactive substances, marks a significant advancement in the safety and understanding of psychedelic therapy. By integrating Miraculix's scientific expertise and QTest technology into Psychedelic Passage's client experiences, the partnership ensures more accurate dosage determination and safer use of psychedelics.

Psychedelic Passage, founded by Jimmy Nguyen and Nicholas Levich in 2019, has been at the forefront of transforming access to psychedelic therapy, offering personalized journeys from preparation to integration. Miraculix, under the leadership of Dr. Felix Blei, Frank Junger, and Roxana Budnik, brings a deep understanding of natural product analysis and psychotropic substances to the table. Their QTest technology is pivotal for analyzing psychoactive compound concentrations, enhancing the safety and efficacy of psychedelic experiences.

This innovative initiative also allows Psychedelic Passage clients to participate in community research projects led by Miraculix. Utilizing tools like the Psilocybin QTest kits, clients can contribute to studies that explore the entourage effect in psychedelic mushrooms, enriching both personal experiences and global psychedelic research. 'We're excited about this partnership,' said Jimmy Nguyen, highlighting the potential to improve client safety and journey effectiveness through Miraculix's scientific analysis.

Dr. Felix Blei of Miraculix emphasized the collaboration's role in advancing harm reduction and empowering individuals with scientific knowledge. The partnership not only aims to make psychedelic therapy safer but also to broaden the understanding of psychedelics' therapeutic potential. For those interested in learning more about this collaboration, Psychedelic Passage's podcast featuring Dr. Blei and the Miraculix Community Research page offer valuable insights.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at Newsworthy.ai